Associations Among Obesity, Acute Weight Gain, and Response to Treatment with Olanzapine in Adolescent Schizophrenia

Neural Correlates of Weight Gain With Olanzapine

(2012) Jose Mathews et al.   ARCHIVES OF GENERAL PSYCHIATRY

Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial

(2012) Robert L. Findling et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)

(2011) T. Scott Stroup et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Randomized, Double-Blind Study of Paliperidone Extended-Release in Treatment of Acute Schizophrenia in Adolescents

(2011) Jaskaran Singh et al.   BIOLOGICAL PSYCHIATRY

Atypical Antipsychotic-Induced Weight Gain

(2011) James L. Roerig et al.   CNS DRUGS

Management of Schizophrenia in Children and Adolescents

(2011) Gabriele Masi et al.   DRUGS

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

(2011) Marc De Hert et al.   Nature Reviews Endocrinology

The association between weight change and symptom reduction in the CATIE schizophrenia trial

(2011) Eric Hermes et al.   SCHIZOPHRENIA RESEARCH

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

(2010) David E Kemp et al.   BIPOLAR DISORDERS

Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008

(2010) Cynthia L. Ogden   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antipsychotic drugs and obesity

(2010) Christoph U. Correll et al.   TRENDS IN MOLECULAR MEDICINE

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia

(2009) Magali Haas et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Preliminary Findings Regarding Overweight and Obesity in Pediatric Bipolar Disorder

(2009) Benjamin Goldstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder

(2009) Ludmila A. Kryzhanovskaya et al.   JOURNAL OF CLINICAL PSYCHIATRY

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia

(2008) Robert L. Findling et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effectiveness of second generation antipsychotics: A systematic review of randomized trials

(2008) Erik Johnsen et al.   BMC Psychiatry

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Ludmila Kryzhanovskaya et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY